Published in DNA Cell Biol on March 14, 2012
Genetics of chronic rhinosinusitis: state of the field and directions forward. J Allergy Clin Immunol (2013) 1.00
ICON: chronic rhinosinusitis. World Allergy Organ J (2014) 0.86
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol (1998) 7.22
COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol (2005) 3.15
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol (2002) 2.84
EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy (2005) 2.07
Prevalence of selected chronic conditions: United States, 1990-1992. Vital Health Stat 10 (1997) 1.73
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology (2005) 1.67
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis (2006) 1.28
Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer (2006) 1.23
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Clin Cancer Res (2005) 1.21
Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci (1999) 1.18
Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther (2001) 1.18
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin Cancer Res (2006) 1.15
Cyclooxygenase-2 and inflammation in atherosclerosis. Curr Opin Pharmacol (2004) 1.11
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer (2005) 1.04
Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J (2000) 1.02
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res (2006) 1.01
Superantigens and nasal polyps. Curr Allergy Asthma Rep (2003) 0.99
Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol (2004) 0.96
Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett (2001) 0.96
COX-2 polymorphisms and the risk for head and neck cancer in white patients. Head Neck (2009) 0.95
Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs (2004) 0.94
The COX-2 promoter polymorphism -765 G>C is associated with early-onset, conventional and stump gastric cancers. Mod Pathol (2008) 0.94
Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am J Respir Cell Mol Biol (1993) 0.94
Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma. World J Gastroenterol (2009) 0.93
COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk. World J Gastroenterol (2009) 0.93
Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats. Cell Tissue Res (2001) 0.93
Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer. J Oncol (2009) 0.92
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis. Thorax (2006) 0.91
Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa. Effects of cytokines and dexamethasone. Clin Exp Allergy (2000) 0.90
Hepatocyte growth factor and the kidney: it is not just for the liver. Int Rev Cytol (1999) 0.89
Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol (1998) 0.88
Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps. Acta Otolaryngol (1988) 0.88
Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index. World J Gastroenterol (2008) 0.87
Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol (2005) 0.86
Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol (2002) 0.84
COX-2 gene promoter polymorphism and coronary artery disease in middle-aged men: the Helsinki sudden death study. Mediators Inflamm (2008) 0.84
Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope (1996) 0.83
Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression. Anal Biochem (1999) 0.82
Airway epithelium wound repair and regeneration after injury. Acta Otorhinolaryngol Belg (2000) 0.77
Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps. Arch Otolaryngol Head Neck Surg (2006) 0.77
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood (2006) 2.18
Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol Cell Biol (2002) 1.60
Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol (2010) 1.53
Effects of three different types of anaesthesia on perioperative bleeding control in functional endoscopic sinus surgery. Eur Arch Otorhinolaryngol (2012) 1.47
Incidence of colorectal cancer in Poland in 1999-2008. Arch Med Sci (2011) 1.25
Tyrosine kinase blockers: new hope for successful cancer therapy. Anticancer Agents Med Chem (2009) 1.19
Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep (2012) 1.08
Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study. Mol Biol Rep (2010) 1.07
Malignant melanoma of the anorectum--a rare entity. Langenbecks Arch Surg (2010) 1.05
Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat (2005) 1.01
Effect of short-term cryostimulation on antioxidative status and its clinical applications in humans. Eur J Appl Physiol (2011) 0.98
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem (2011) 0.95
Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci (2012) 0.94
Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res (2011) 0.93
Thermostability gradient in the collagen triple helix reveals its multi-domain structure. J Mol Biol (2004) 0.93
Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med (2013) 0.92
An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2007) 0.92
Procollagen VII self-assembly depends on site-specific interactions and is promoted by cleavage of the NC2 domain with procollagen C-proteinase. Biochemistry (2003) 0.91
Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol (2011) 0.90
Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility. J Biol Chem (2012) 0.90
Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine. Chem Biol Interact (2002) 0.89
Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer (2012) 0.89
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases. Pol Przegl Chir (2011) 0.88
Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res (2009) 0.88
Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism. Mutat Res (2010) 0.86
The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking- and drinking-associated larynx cancer. Tohoku J Exp Med (2009) 0.85
Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anticancer Drugs (2005) 0.84
Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland. Mol Biol Rep (2012) 0.83
The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer. DNA Cell Biol (2012) 0.83
Evaluation of DNA double strand breaks repair efficiency in head and neck cancer. DNA Cell Biol (2011) 0.83
MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study. Mol Biol Rep (2010) 0.83
An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer. Mutat Res (2013) 0.83
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol (2013) 0.83
Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res (2010) 0.82
Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy. Exp Eye Res (2008) 0.82
Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma. Acta Ophthalmol (2013) 0.82
Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population. Med Oncol (2014) 0.82
Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: role in drug resistance? Leuk Res (2003) 0.81
The protective role of the -735C/T and the -1306C/T polymorphisms of the MMP-2 gene in the development of primary open-angle glaucoma. Ophthalmic Genet (2013) 0.81
Direct current stimulation of the ear in tinnitus treatment: a double-blind placebo-controlled study. Eur Arch Otorhinolaryngol (2013) 0.81
The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population. Mol Biol Rep (2014) 0.81
Association of MMP1-1607 1G/2G and TIMP1 372 T/C gene polymorphisms with risk of primary open angle glaucoma in a Polish population. Med Sci Monit (2011) 0.81
Association of polymorphism of Lys589Glu Exo1 gene with the risk of colorectal cancer in the Polish population. Pol Przegl Chir (2014) 0.80
[The effects of whole-body cryotherapy and melatonin supplementation on total antioxidative status and some antioxidative enzymes in multiple sclerosis patients]. Pol Merkur Lekarski (2011) 0.80
Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease. Kardiol Pol (2008) 0.80
The c.469+46_56del mutation in the homeobox MSX1 gene--a novel risk factor in breast cancer? Cancer Epidemiol (2010) 0.80
The application of direct current electrical stimulation of the ear and cervical spine kinesitherapy in tinnitus treatment. Auris Nasus Larynx (2012) 0.80
[Influence of positional blood flow disorders in the vertebral and basilar arteries on the prevalence of vertigo in patients with cervical spondylosis]. Pol Merkur Lekarski (2005) 0.80
Association of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population. Pol J Pathol (2013) 0.80
Lack of association between the 135G/C RAD51 gene polymorphism and the risk of colorectal cancer among Polish population. Pol Przegl Chir (2012) 0.79
Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance. Comp Biochem Physiol C Toxicol Pharmacol (2006) 0.79
Effect of Cu(II) coordination compounds on the activity of antioxidant enzymes catalase and superoxide dismutase in patients with colorectal cancer. Pol Przegl Chir (2011) 0.79
Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol (2013) 0.79
A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer. Pol Przegl Chir (2011) 0.78
Association of -1112 c/t promoter region polymorphism of the interleukin 13 gene with occurrence of colorectal cancer. Pol Przegl Chir (2011) 0.78
[Genetic predeterminations of head and neck cancer]. Postepy Hig Med Dosw (Online) (2008) 0.78
Comparative study of DNA damage and repair in head and neck cancer after radiation treatment. Cell Biol Int (2009) 0.78
Evaluation of oxidative DNA damage and antioxidant defense in patients with nasal polyps. Redox Rep (2015) 0.77
[Tinnitus and depression]. Otolaryngol Pol (2009) 0.77
Neurodegenerative Genes Polymorphisms of the -491A/T APOE, the -877T/C APP and the Risk of Primary Open-angle Glaucoma in the Polish Population. Ophthalmic Genet (2013) 0.77
Association of the -33C/G OSF-2 and the 140A/G LF gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population. Mol Biol Rep (2011) 0.77
[Matrix metalloproteinases (MMPs): modern molecular markers of open-angle glaucoma diagnosis and therapy]. Postepy Hig Med Dosw (Online) (2008) 0.77
[Molecular basis of diabetic retinopathy]. Postepy Hig Med Dosw (Online) (2007) 0.77
[Influence of complex deacon-tetra (N1,3-triazole,кN2) copper (II) on the barrier and antioxidant pro people with nasal polyps]. Otolaryngol Pol (2013) 0.76
Expression of the PLS3 Gene in Circulating Cells in Patients with Colorectal Cancer. Pol Przegl Chir (2015) 0.76
DNA damage and oxidant-antioxidant status in blood of patients with head and neck cancer. DNA Cell Biol (2014) 0.76